XML 78 R25.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Insider Trading Arrangements
 3 Months Ended
Mar. 31, 2024
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Peter J. Bulgarelli [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On March 11, 2024, Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research of the Company and President and CEO of Lillibridge Healthcare Services, Inc., adopted a new trading plan intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Mr. Bulgarelli’s trading plan is for the sale of up to 22,500 shares of our common stock in amounts and prices determined in accordance with a formula set forth in the plan and terminates on the earlier of the date all the shares under the plan are sold and March 11, 2025.
Name Peter J. Bulgarelli
Title Executive Vice President, Outpatient Medical & Research of the Company and President and CEO of Lillibridge Healthcare Services, Inc
Rule 10b5-1 Arrangement Adopted true
Adoption Date March 11, 2024
Arrangement Duration 365 days
Aggregate Available 22,500
Debra A. Cafaro [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On March 28, 2024, Debra A. Cafaro, Chairman and CEO of the Company, adopted a new trading plan intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Ms. Cafaro’s trading plan is with respect to her expiring options and covers the potential exercise and sale of up to 1,546,317 shares of our common stock in amounts and prices
determined in accordance with a formula set forth in the plan and terminates on the earlier of the date all the shares under the plan are sold and January 15, 2027.
Name Debra A. Cafaro
Title Chairman and CEO of the Company
Rule 10b5-1 Arrangement Adopted true
Adoption Date On March 28, 2024
Arrangement Duration 1023 days
Aggregate Available 1,546,317